Back to results
US 10,539,567 B2Granted
Biopsy methods and devices
AssigneeIndicator Systems International, Inc.
InventorsGerald F. Swiss, John V. Fante, Robert M. Moriarty, Richard J. Pariza
Life of this patent
Estimating the term…
Abstract
Disclosed are methods for detecting remnant cancer cells in a tissue sample.
Claims4
A method for detecting the presence or absence of cancer cells in an excised cellular mass comprising viable cells which are suspected of including cancer cells which method comprises:
- contacting said mass with a conjugate comprising a tumor targeting component and a pro-detection component so that the conjugate selectively binds to and is then absorbed by any cancer cells in said mass that it targets whereupon the pro-detection component is intracellularlv converted into a detection component with a signaling fingerprint;
- evaluating the contacted mass for signal generated from the detection component of said conjugate;
- and
- correlating the presence or absence of said signal fingerprint to the presence or absence of cancer cells;
- wherein said conjugate is a compound of formula I:
- wherein R and R1 are independently C2-C18 alkyl or cycloalkyl groups both of which contain 1 to 8 heteroatoms selected from the group consisting of oxygen, S(O)x, >NR3, —OP(O)yH, —OS(O)zH, —C(O)—, amino, C1-C6 alkylamino, di(C1-C6dialkyl)amino, —C(O)O—, —C(O)NR3—, —C(O)OH, —OH, and oxo wherein y and z are independently 1 or 2, and x is 0, 1 or 2;
- R2 is hydrogen or methyl;
- R3 is hydrogen or C1-C6 alkyl;
- and
- L is a linker of from 1 to 20 carbon atoms and 1 to 6 heteroatoms selected from the group consisting of oxygen, S(O)x, >NR3, —OP(O)yH, —OS(O)zH, —C(O)—, amino, C1-C6 alkylamino, di(C1-C6 dialkyl)amino, —C(O)O—, —C(O)NR3—, —C(O)OH, —OH, and oxo wherein y and z are independently 1 or 2, and x is 0, 1 or 2;
- or pharmaceutically acceptable salts, tautomers, and/or solvates thereof.
8 more elements
A method for detecting the presence or absence of cancer cells in an excised cellular mass comprising viable cells which are suspected of including cancer cells which method comprises:
- contacting said mass with a conjugate comprising a tumor targeting component and a pro-detection component so that the conjugate selectively binds to and is then absorbed by any cancer cells in said mass that it targets whereupon the pro-detection component is intracellularly converted into a detection component with a signaling fingerprint;
- evaluating the contacted mass for signal generated from the detection component of said conjugate;
- and
- correlating the presence or absence of said signal fingerprint to the presence or absence of cancer cells,
- wherein said conjugate is a compound of formula II:
- wherein R and R1 are independently C2-C18 alkyl or cycloalkyl groups both of which contain 1 to 8 heteroatoms selected from the group consisting of oxygen, S(O)x, >NR3, —OP(O)yH, —OS(O)zH, —C(O)—, amino, C1-C6 alkylamino, di(C1-C6 dialkyl)amino, —C(O)O—, —C(O)NR3—, —C(O)OH, —OH, and oxo wherein y and z are independently 1 or 2, and x is 0, 1 or 2;
- R3 is hydrogen or C1-C6 alkyl;
- and
- L is a linker of from 1 to 20 carbon atoms and 1 to 6 heteroatoms selected from the group consisting of oxygen, S(O)x, >NR3, —OP(O)yH, —OS(O)zH, —C(O)—, amino, C1-C6 alkylamino, di(C1-C6 dialkyl)amino, —C(O)O—, —C(O)NR3—, —C(O)OH, —OH, and oxo wherein y and z are independently 1 or 2, and x is 0, 1 or 2;
- or pharmaceutically acceptable salts, tautomers, and/or solvates thereof.
7 more elements
Dependencies are inferred from the claim text.